A method employing trifluoroacetic acid for the quantitative determination ofallrrans-retinoic acid and 13-cis-retinoic acid in serum is described. The method permits the detection of as little as 0.3 Kg of either compound. Retinoic acid can serve the general tissue functions of vitamin A, except i
Anti-inflammatory effects of 13-cis-retinoic acid
β Scribed by Gerd Plewig; Annemarie Wagner
- Publisher
- Springer-Verlag
- Year
- 1981
- Tongue
- English
- Weight
- 330 KB
- Volume
- 270
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
β¦ Synopsis
Sixteen patients with care acne conglobata, acne fulminans, acme tetrade were treated orally with 13-cis-retinoic acid, 1-2 mg/kg body weight for 12 weeks. A maintenance dose of 0.5 mg/kg in ten cases and the use of no further medication in six other cases for an additional 12 weeks followed. A 40% potassium iodide ointment was used on the upper back under occlusive dressing conditions to induce an inflammatory reaction. Four inflammatory parameters were assessed in all subjects before and during oral treatment: erythema (0-2+), edema (0-2+), papules (numbers), and pustules (numbers). All patients showed excellent improvement. Additionally, the inflammatory reaction in all patch-tests was significantly reduced: erythema from 1.13 to 0.34 (P less than or equal to 0.01); edema from 1.06 to 0.25 (P less than or equal 0.0005); papules from 6.75 to 1.86 (P less than or equal to 0.01); and pustules from 10.44 to 1.56 (P less than or equal to 0.0025). We suggest that 13-cis-retinoic acid acts as a strong anti-inflammatory agent in addition to its known function as a sebostaticum.
π SIMILAR VOLUMES
## SYNTHESIS OF 13-e-(ll-3H)-RETINOIC ACID The b i o l o g i c a l a c t i v i t y of 1 3 -e -r e t i n o i c a c i d i n p r e v e n t i o n of e p i t h e l i a l cancer i n animals h a s r e c e n t l y been demonstrated [l]. I n c o n n e c t i o n w i t h a m e t a b o l i c s t u d i e s pro
## Abstract A route to crystalline 13β__cis__βretinoic acidβ**6**,**7**β^14^__C__ (**1**) has been developed. Addition of acetyleneβ**1**,**2**β^14^**C** to 6βmethylβ5βheptenβ2βone (**4**) gave dehydrolinaloolβ**1**,**2**β^14^__C__ (**5**) which was catalytically transformed into citralβ**1**,**2**
Animal studies indicate that 13-cis-retinoic acid (CRA) inhibits bladder tumor growth and is effective in treating patients with serious dermatologic disorders. A trial of CRA in patients at high risk for recurrent Ta, T l tumors was initiated at an experimental dose of 0.5 mg/kg/d in three divided
The pharmacokinetics of three 13-cis-retinoic acid formulations were studied after intraperitoneal (ip) administration to rats. Rats were given ip injections of 2.5 mg of 13-cis-retinoic acid per 360 g of body weight; the drug was administered as an alkaline solution, suspended in corn oil, or as a